洞察癌症相关的血栓形成,导致缺血性中风
Surajit Hansda1, Hiranmoy Das1
1Department of Pharmaceutical Sciences, Jerry H. Hodge School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, TX 79106, USA.
Biology
|January 25, 2025
概括
癌症显著增加了中风风险,由于先进的癌症治疗,癌症相关性中风 (CAS) 发生率上升. 本综述详细介绍了CAS机制,风险因素和管理策略,以改善患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 神经学 神经学
- 血管医学 血管医学
背景情况:
- 脑卒中是导致残疾的主要原因,并且越来越多地认识到它与癌症的关联.
- 癌症相关中风 (CAS) 发病率正在上升,这是由于癌症存活率和治疗方法的改善.
- 癌症通过直接影响,高凝血状态,感染和癌症治疗影响中风风险.
研究的目的:
- 审查癌症患者中风的流行病学,病理生理学和机制.
- 讨论生物标志物,信号通路和涉及CAS的转录因子.
- 为癌症相关缺血性中风的治疗和管理提供见解.
主要方法:
- 关于癌症和中风研究的综合文献综述.
- 分析机制,包括直接的瘤效应,凝血和与治疗相关的风险.
- 探索诸如动脉样硬化和细胞外囊泡之类的促成因素.
主要成果:
- 癌症是中风的重要危险因素,各种癌症类型与缺血事件有关.
- 癌症治疗 (化疗,放射治疗,手术) 会增加中风的风险.
- 动脉样硬化,EV和生物分子在CAS病理生理学中发挥作用.
结论:
- 脑卒中是癌症患者常见和严重的并发症.
- 迫切需要瘤学家和神经病学家之间的协作策略来进行CAS查和预防.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
602
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
602
Intracellular Signaling Affects Focal Adhesions
2.5K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.5K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Disorders of Hemostasis
690
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
690
Cancer Stem Cells and Tumor Maintenance
4.7K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.7K


